As the pooled analysis for the association of IL‐1B −511 and +3954 polymorphisms with cancer risk have been performed elsewhere in May 2013 7, we only focused on IL‐1B 31 polymorphism in the present study. The gene discussed is IL1B; the disease is cancer.